Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”? You might be interested in our paper now out in Circulation Circulation #simultaneouspublication #AHA23 #cardiotwitter #WhyCMR

🔴 Cardiac amyloidosis and aortic stenosis: a state-of-the-art review European Society of Cardiology Journals #CardioEd #Cardiology #Amyloidosis #CardioTwitter

Pretty amazing. 🤯 No (zero!) false positive ischemia findings by exercise stress #ECG ⚡️when invasive coronary physiological testing of #CMD is the reference standard. So, all w pos stress ECG have some form of 🫀myocardial ischemia, incl CMD.

Today at 4PM EST! Webinar on State of the Art Imaging of Infiltrative Cardiomyopathies. REGISTER: heart.zoom.us/webinar/regist… Jiwon Kim, MD Kaz Negishi@Cardiologist/ Heart Mafia #AHAJournals

Valvular heart disease and cardiomyopathy: reappraisal of their interplay Nature Reviews Cardiology nature.com/articles/s4156…

Echocardiographic estimation of pulmonary artery wedge pressure: invasive derivation, validation, and prognostic association beyond diastolic dysfunction grading Read the full text in the last issue of #EHJCVI European Society of Cardiology Journals EACVI President #echofirst academic.oup.com/ehjcimaging/ar…

Alright, by popular request from like one person and to amuse basically just myself… here’s #MetGala 2024 outfits as medical specialties for a third year in a row

Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy | JACC: Cardiovascular Imaging Congratulations to James moon and all the team for providing these highly needed thresholds of segmental indexed apical wall thickness #WhyCMR EACVI President Thomas Treibel

Thanks Angelique Opie for this story about our trial evaluating the use of romosozumab in patients with multiple myeloma who experience skeletal related events including fracture - which is currently open at @SVHSydney The Kinghorn Cancer Centre Garvan Institute of Medical Research

Wonderful to be at @ISA2024 together! DrElleRye The International Society Of Amyloidosis

Very proud to see #ISA2024 day 2 symposium kicked off with the incredible Dr Antonia Carroll! @DrNikkiBart DrElleRye @SVHSydney Victor Chang Cardiac Research Institute #amyloid #isa

Assessing diastology in AF is a nightmare despite the two being tightly coupled. These guidelines by BSEcho provide a framework. Very exciting to see Atrial strain being incorporated to help assess la filling pressure echo@nepean

Amazing presentation by Brett Sperry, MD detailing tafamidis long term data 1)Continued survival benefit in the longterm. 2) stabilized eGFR compared to placebo 3) reduced decline in health status and functional capacity in octogenarians 4) benefit in NYHA3

I made this one just for you 🇳🇴🇩🇰Asbjørn Støylen 🇬🇱🇵🇸🇺🇦 🤣🤣🤣 #Echofirst #Cardiotwitter #Medtwitter #MAPSE #function

Great to see amyloid up on the big screen at #ESCCongress2024. Standing room only following hotline results of HELIOS-B earlier this week. Exciting times for targeted treatment in cardiomyopathies ❤️ #amyloid The International Society Of Amyloidosis Australian Amyloidosis Network European Society of Cardiology #CardioTwitter

Blink and you’ll miss it - that’s the 2024 #ESCCongress wrapped. Going to need to practise my conference selfie if I’m going to measure up to @NSLHD ‘s Dr Anastasia Mihailidou FAHA FCSANZ FESC

I’m delighted that Echo IQ (ASX:EIQ) has its first FDA clearance for EchoSolv AS. First ever Echocardiography measurement decision-support AI to be cleared in USA. Identifies high risk severe AS phenotype: jacc.org/doi/10.1016/j.… Watch this space! Jordan Strom, MD, MSc, FACC, FASE Echofirst Bot American Society of Echocardiography

Very grateful to Heart Foundation for supporting my PhD! Looking forward to exploring gene-environment interactions and preventative therapies in inherited heart disease with support from Victor Chang Cardiac Research Institute and my stellar supervisors @FatkinLab @DrNikkiBart & Prof Nigel Turner

Tirzepatide reduced circulatory volume–pressure overload and systemic inflammation and mitigated cardiovascular–kidney end-organ injury in patients with HFpEF and obesity. New mechanistic insights from the SUMMIT trial in Nature Medicine nature.com/articles/s4159…

Very excited to share our newly published review on atrial cardiomyopathy in amyloidosis! nature.com/articles/s4432… DrElleRye @DrNikkiBart @FatkinLab Georgia McCaughan Victor Chang Cardiac Research Institute